GlassScriptPhysician profile
Athena Tuot
NPI 1134745623
$1,788.72
in general payments reported to CMS, 2019-2025
19 companies · $851 in 2025
The $851 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.20 · 2023: $544 · 2024: $355 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,736 · Travel and Lodging: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,735.52 |
| Travel and Lodging | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $441.31 | 2023 | Intracept |
| Boston Scientific Corporation | $290.05 | 2025 | Intracept |
| Collegium Pharmaceutical, INC. | $275.38 | 2022-2025 | Belbuca, Xtampza |
| Foundation Fusion Solutions, LLC | $146.72 | 2025 | |
| Abbott Laboratories | $133.88 | 2025 | Eterna |
| Vertos Medical, INC. | $94.01 | 2024 | Mild Device Kit |
| Saluda Medical Americas, INC. | $73.28 | 2024-2025 | Evoke |
| Spinal Simplicity, LLC | $45.70 | 2025 | Ha Minuteman G3-R |
| Virtus Pharmaceuticals LLC | $43.90 | 2024-2025 | Levorphanol Tartrate |
| Valinor Pharma, LLC | $35.00 | 2024 | Movantik |
| Nevro Corp. | $31.83 | 2023 | Senza |
| Vertex Pharmaceuticals Incorporated | $30.10 | 2025 | |
| International Rehabilitative Sciences, INC | $29.48 | 2024-2025 | Rs 4i Plus Sequential Stimulator, Rs-4i Plus With Intersperse |
| Biotronik Nro, INC. | $27.04 | 2025 | Prospera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.20 | 2025 | Relistor |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $23.23 | 2022 | |
| Averitas Pharma INC. | $22.47 | 2023 | Qutenza |
| Curonix LLC | $16.16 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Electronic Waveform Lab, INC. | $4.98 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Athena Tuot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.